FDA Launches Safety Review Of Weight Loss Drug
The U.S. Food and Drug Administration has launched an expedited safety review of sibutramine based on a recent study showing that some patients taking the weight loss drug, which Abbott Laboratories...To view the full article, register now.
Already a subscriber? Click here to view full article